Stocks
Heron Therapeutics (HRTX) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -7.43 | -7.61 | -4.14 | -1.97 | -3.10 | -4.89 | ||
| Changes by years, y/y, % | -13% | +2% | -46% | -52% | +57% | -18.3% | |||
Heron Therapeutics. EV/EBITDA
Heron Therapeutics. EV/EBITDA, changes, %
Heron Therapeutics (HRTX) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| EV/EBITDA | ? | -1.93 | -2.12 | -3.29 | -6.62 | -14.8 | -4.89 | |
| Changes by years, y/y, % | +17% | -13% | +53% | +241% | +665% | |||
| Changes by quarters, q/q, % | 0% | +10% | +55% | +101% | +123% | |||
